{
    "2019-09-09": [
        [
            {
                "time": "2019-09-09",
                "original_text": "After Hours Most Active for Sep 9, 2019: CSCO, CY, CMCSA, COG, SBBP, LYFT, T, ELAN, WBA, PFE, HES, MS",
                "features": {
                    "keywords": [
                        "Most Active",
                        "CSCO",
                        "CY",
                        "CMCSA",
                        "COG",
                        "SBBP",
                        "LYFT",
                        "T",
                        "ELAN",
                        "WBA",
                        "PFE",
                        "HES",
                        "MS"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-09",
                "original_text": "Amarin: Keep Your Dry Powder Ready",
                "features": {
                    "keywords": [
                        "Amarin",
                        "Dry Powder"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-09",
                "original_text": "Health Care Sector Update for 09/09/2019: ACAD, AXNX, AMGN, JNJ, PFE, ABT, MRK",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "ACAD",
                        "AXNX",
                        "AMGN",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-09",
                "original_text": "Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks?",
                "features": {
                    "keywords": [
                        "Stocks To Buy",
                        "Large-Cap Stocks"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-09",
                "original_text": "Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Positive Preliminary Results",
                        "Proof-of-Concept",
                        "Phase 2 Study",
                        "Vaccine Candidate"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}